Predictors of major adverse cardiac events, high radiation exposure, and contrast use in percutaneous coronary interventions for calcified lesions
Advances in Interventional Cardiology · 2026 · 22 (1) · 8-20
DOI: 10.5114/aic.2026.160014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Interventional Cardiology, 2026. Verfasst von Christos N Bousis und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medical Physics Department, General Hospital of Ioannina "CHATZIKOSTA", Ioannina, Greece. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Physics Department, General Hospital of Ioannina "CHATZIKOSTA", Ioannina, Greece.
- Cardiology Clinic, Haemodynamics Department, General Hospital of Ioannina "CHATZIKOSTA", Ioannina, Greece.
Zitieren
APA
Bousis, C. N., Kalampoki, E., Kotsia, A., Karanikis, P., Kosovitsas, A., Tzima, E., Beli, V., & Pappa, E. (2026). Predictors of major adverse cardiac events, high radiation exposure, and contrast use in percutaneous coronary interventions for calcified lesions. Advances in Interventional Cardiology, 22(1), 8-20. https://doi.org/10.5114/aic.2026.160014
Vancouver
Bousis CN, Kalampoki E, Kotsia A, Karanikis P, Kosovitsas A, Tzima E, et al. Predictors of major adverse cardiac events, high radiation exposure, and contrast use in percutaneous coronary interventions for calcified lesions. Advances in Interventional Cardiology. 2026;22(1):8-20. doi:10.5114/aic.2026.160014
BibTeX
@article{Bousis2026,
author = {Bousis, Christos N and Kalampoki, Evaggelia and Kotsia, Anna and Karanikis, Pavlos and Kosovitsas, Athanasios and Tzima, Eleni and Beli, Vasiliki and Pappa, Evgenia},
title = {Predictors of major adverse cardiac events, high radiation exposure, and contrast use in percutaneous coronary interventions for calcified lesions},
journal = {Advances in Interventional Cardiology},
year = {2026},
volume = {22},
number = {1},
pages = {8--20},
doi = {10.5114/aic.2026.160014}
}
EUVIMED